LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9426 | 10512 | 0.8969 | 0.9378 |
MCF 10A | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 962 | 3910 | 10512 | 0.3727 | 0.4995 |
MCF 10A | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 962 | 1676 | 10512 | 0.1595 | 0.1742 |
MCF 10A | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1141 | 10512 | 0.1086 | 0.0507 |
MCF 10A | Dovitinib | 10 | uM | LJP5 | 72 | hr | 962 | 921 | 10512 | 0.0876 | -0.0128 |
MCF 10A | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10482 | 10512 | 0.9972 | 0.9984 |
MCF 10A | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 962 | 9800 | 10512 | 0.9325 | 0.9597 |
MCF 10A | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 962 | 8775 | 10512 | 0.8351 | 0.8980 |
MCF 10A | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 962 | 8343 | 10512 | 0.7935 | 0.8702 |
MCF 10A | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 962 | 8202 | 10512 | 0.7803 | 0.8612 |
MCF 10A | GSK 690693 | 10 | uM | LJP5 | 72 | hr | 962 | 8706 | 10512 | 0.8283 | 0.8937 |
MCF 10A | SNS-032 | 0.04 | uM | LJP6 | 72 | hr | 962 | 9838 | 10692 | 0.9202 | 0.9527 |
MCF 10A | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 962 | 1209 | 10692 | 0.1131 | 0.0680 |
MCF 10A | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 962 | 452 | 10692 | 0.0423 | -0.1955 |
MCF 10A | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 962 | 294 | 10692 | 0.0276 | -0.2895 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 962 | 273 | 10692 | 0.0256 | -0.3071 |
MCF 10A | SNS-032 | 10 | uM | LJP6 | 72 | hr | 962 | 324 | 10692 | 0.0303 | -0.2777 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 1713 | 10692 | 0.1603 | 0.1807 |
MCF 10A | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 1521 | 10692 | 0.1423 | 0.1408 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 1405 | 10692 | 0.1314 | 0.1150 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 962 | 1383 | 10692 | 0.1293 | 0.1099 |
MCF 10A | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 1483 | 10692 | 0.1388 | 0.1327 |
MCF 10A | Afatinib | 10 | uM | LJP6 | 72 | hr | 962 | 1227 | 10692 | 0.1148 | 0.0724 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 962 | 9104 | 10692 | 0.8515 | 0.9095 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 962 | 8802 | 10692 | 0.8232 | 0.8909 |